MIRA
INFORM REPORT
|
Report Date : |
29.12.2007 |
IDENTIFICATION
DETAILS
|
Name : |
CELLOFARM LTDA |
|
|
|
|
Registered Office : |
Rodovia Br Km 271 – S/N – QD 9 M 1 QD 10 M 3, Setor
Industrial – 22793-080 Rio de, Janeiro/RJ,
|
|
|
|
|
Country : |
Brasil |
|
|
|
|
Financials (as on) : |
2007 |
|
|
|
|
Date of Incorporation : |
27.01.1998 |
|
|
|
|
Com. Reg. No.: |
32.201.053.001 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Industry of pharmaceutical products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
Head information
Company name: CELLOFARM
LTDA.
Trade Name: CELLOFARM
Economical Group: STRIDES
LATINA
Address: Rodovia
Br Km 271 – S/N – QD 9 M 1 QD 10 M 3, Setor Industrial – 22793-080 Rio de
Janeiro/RJ,
Brasil
Phone: (55-21)
2493 0794
E-mail: salles@cellfarm.com.br
Web Site: www.cellfarm.com.br
Legal information
Legal Status: Private
Limited Company
Incorporation date: January
27, 1998
Register number #: 32.201.053.001
Tax contributor (CNPJ): 02.433.631/0001-20
Registered Capital: R$20.142.770,00
State Registration #: 082.086.67-2
Number of employees: Not
informed.
Branches: 05
History
Established on January 27, 1998, chartered at the State Commerce
Registration Office of Rio de Janerio (JUCERJ) under #32.201.053.001, into the
present registered name.
The company incorporated in 08/2003 Infarma Indústria Farmaceutica
Brasileira Ltda.
Shareholders/Partnership:
Strides Latina S/A. -
99,9%
Uruguay, CNPJ:07.164.592/0001-26
Lincoln Colares Gomes - 0,1%
Brazilian, CPF:510.533.307-15
Management:
Lincoln Colares Gomes -
Financial director
Brazilian, Married, CPF:510.533.307-15
Properties
Not informed.
Registered line of business:
Industry of pharmaceutical products
Main Products:
Medicines
Import countries:
Not informed.
Export countries:
Not informed.
Purchases:
100% - Domestic market
Related Companies
Stock participation:
Not informed.
Financial Data
According to the Brazilian Law Private Limited Companies are not obliged
to file financial accounts for public inspection.
The following financial statement was obtained through outside sources
consulted.
Quarterly balance sheet as of 31/04/2007 – US$1.00 = R$2,034
Balance sheet information for fiscal year ending:
31/12/2006 – US$1.00 = R$2,138
31/12/2005 – US$1.00 = R$2,341
Figures are in (Thousands of) Reais R$:
|
Assets |
04/2007 |
2006 |
2005 |
|
Current Assets |
80.440 |
79.283 |
66.162 |
|
Inventory |
11.143 |
18.776 |
17.537 |
|
Other Assets |
69.297 |
60.507 |
48.625 |
|
Fixed Assets |
73.924 |
62.490 |
42.941 |
|
Immovable |
28.338 |
28.416 |
32.872 |
|
Deferred |
45.586 |
34.074 |
10.069 |
|
Total Assets |
154.364 |
141.773 |
109.103 |
|
Liabilities |
04/2007 |
2006 |
2005 |
|
Current Liabilities |
50.091 |
44.299 |
17.043 |
|
Suppliers |
1.861 |
1.988 |
1.703 |
|
Other liabilities |
48.230 |
42.311 |
15.340 |
|
Long Term Liabilities |
72.481 |
67.101 |
60.165 |
|
Net Equity |
31.792 |
30.373 |
31.895 |
|
Capital |
20.143 |
20.143 |
20.143 |
|
Reserves |
10.230 |
4.621 |
4.147 |
|
Accumulated Profit (Loss) |
1.419 |
5.609 |
7.605 |
|
Total Liabilities |
154.364 |
141.773 |
109.103 |
|
Income Statement |
04/2007 |
2006 |
2005 |
|
Annual Net Sales |
29.639 |
102.081 |
101.260 |
|
Gross Income |
11.998 |
37.669 |
41.728 |
|
Operating Income |
1.417 |
6.358 |
9.334 |
|
Net Income |
1.417 |
5.608 |
7.606 |
|
Financial Analysis |
04/2007 |
2006 |
2005 |
|
Current Ratio |
1,60 |
1,78 |
3,88 |
|
Current Debt
Ratio |
1,57 |
1,45 |
0,53 |
|
Total Debt Ratio |
4,85 |
4,66 |
3,42 |
|
Working Capital |
$30.349 |
$34.984 |
$49.119 |
Dollar rate US$1.00 = R$1,767
Banking
Remark: banking comments could not be obtained due
to legal restrictions from the Brazilian Law.
No returned checks were found either in the name of the company or
partners.
Insurance
Not informed.
Payment information
*Information obtained from outside sources and public consulted.
100 – Invoices:
|
Information on
purchases: |
||||
|
DEC/2007 |
Last: |
R$603 |
Average: |
R$3.273 |
|
Information on
invoicing: |
||||
|
MAR/2007 |
Highest: |
R$29.750 |
Average: |
R$6.233 |
|
Information on accumulation: |
||||
|
FEB/2007 |
Highest: |
R$40.215 |
Average: |
R$7.608 |
85% - Prompt payments
05% - Delays from 08 up to 15 days
06% - Delays from 16 up to 30 days
03% - Delays from 31 up to 60 days
01% - With superior delays to 60 days
Trade References
Main Supplier:
Bafema Indústria de Embalagens Ltda.
Main clients:
Drogarias Pacheco S/A.
Mednews Produtos Farmacêutico Ltda.
Public Records
Information
Up to December 27, 2007, no negative information was found.
03 protested bills, on the amont of R$14.953,76:
11/Dec/2007 – R$6.276,55
- Serra / ES
03/Dec/2007 – R$8.107,21
- Serra / ES
29/Nov/2007 – R$ 570,00 - Campos de Goytacazes / RJ
Remarks
Contacted Mr. Renato Salles, we requested information, however until the
moment we didn't receive an answer.
The information in this report were obtained from outside sources and
public records consulted.
Final Opinion
We believe it may be possible to have trade relation with the subject
company with amounts that fit to its economic-financial resources, under usual
terms. When higher amounts are involved we recommend dealing under secured
terms.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)